Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_assertion type Assertion NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_head.
- NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_assertion description "[in breast cancer patients, Akt activation is associated with tumour proliferation and poor prognosis, particularly in the subset of patients with ErbB2-overexpressing tumours ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_provenance.
- NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_assertion evidence source_evidence_literature NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_provenance.
- NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_assertion SIO_000772 15987444 NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_provenance.
- NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_assertion wasDerivedFrom lhgdn-20090331 NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_provenance.
- NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_assertion wasGeneratedBy ECO_0000203 NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_provenance.